FSPHX
Price
$25.51
Change
+$0.24 (+0.95%)
Updated
Jun 6 closing price
Net Assets
5.86B
LHCOX
Price
$18.52
Change
+$0.04 (+0.22%)
Updated
Jun 6 closing price
Net Assets
7.33M
Interact to see
Advertisement

FSPHX vs LHCOX

Header iconFSPHX vs LHCOX Comparison
Open Charts FSPHX vs LHCOXBanner chart's image
Fidelity Select Health Care
Price$25.51
Change+$0.24 (+0.95%)
VolumeN/A
Net Assets5.86B
Lord Abbett Health Care F3
Price$18.52
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets7.33M
FSPHX vs LHCOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. LHCOX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Buy and LHCOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.86B vs. LHCOX (7.33M). LHCOX pays higher dividends than FSPHX: LHCOX (0.61) vs FSPHX (0.02). FSPHX was incepted earlier than LHCOX: FSPHX (44 years) vs LHCOX (6 years). LHCOX (2.99) is less costly to investors than FSPHX (0.63). LHCOX is a more actively managed with annual turnover of: 88.00 vs. FSPHX (40.00). FSPHX (0) and LHCOX (0) have matching initial minimum investment requirements. LHCOX annual gain was more profitable for investors over the last year : -5.26 vs. FSPHX (-12.67). LHCOX return over 5 years is better than : 7.64 vs. FSPHX (-13.93).
FSPHXLHCOXFSPHX / LHCOX
Total Expense Ratio0.630.6893%
Annual Report Gross Expense Ratio0.632.9921%
Fund Existence44 years6 years-
Gain YTD-7.266-4.840150%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.86B7.33M79,943%
Annual Yield % from dividends0.020.613%
Returns for 1 year-12.67-5.26241%
Returns for 3 years-1.509.74-15%
Returns for 5 years-13.937.64-182%
Returns for 10 years8.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNRX71.38N/A
N/A
Janus Henderson Growth And Income R
PGRUX9.56N/A
N/A
Principal Global Real Estate Sec R5
TEMUX14.87N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
SCIUX11.18N/A
N/A
Invesco Income Advantage U.S. Fund R5
GEBRX10.73N/A
N/A
Goldman Sachs ESG Em Mkts Eq R